Compare ADMA Biologics Inc (ADMA) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Cintas Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation is far larger — about 37× ADMA Biologics Inc's market cap, and Cintas Corporation pays a 1.01% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CTAS | |
|---|---|---|
Market Cap | $2.22B | $82.15B |
Sector | Health | Industrials |
52-Week High | $20.38 | $225.10 |
52-Week Low | $7.60 | $163.55 |
Enterprise Value | $2.29B | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
